Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women

BackgroundAdding testosterone to hormonal therapy could improve sexual function and general well-being among women during climacteric. We evaluated the effectiveness of testosterone undecanoate on sexual function in postmenopausal women utilizing the standardized questionnaire FSFI score.MethodsPostmenopausal women with sexual complaints and Female Sexual Function Index (FSFI) ≤ 26.5 were enrolled in to this randomized, double-blinded, placebo-controlled trial. Participants were randomly assigned to 8-week treatment with either oral testosterone undecanoate 40 mg or placebo twice weekly with daily oral estrogen. The FSFI scores before and after treatment were compared to assess any improvement of sexual function.ResultsSeventy women were recruited of which each group had 35 participants. The baseline characteristics and baseline FSFI scores were comparable between both groups. After 8 weeks of treatment, the FSFI scores significantly improved in both groups when compared to the baseline but the FSFI scores from the testosterone group were significantly higher than in the placebo group post-treatment (28.6 ± 3.6, 25.3 ± 6.7, respectively, p = 0.04). There was no difference in adverse effect between the two groupsConclusionsThe twice weekly addition of testosterone undecanoate to daily oral estrogen was associated with a significant improvement in sexual function among postmenopausal women than the use of the estrogen alone.Trial registrationClinicalTrials.gov Identifier NCT01724658 (February 17, 2012).

• Publication year

  2015

• Venue

  BMC Women's Health

• Publication date

  2015-12-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s12905-015-0270-6PMID 26631095PMCID 4668626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pathophysiology of hypoactive sexual desire disorder in women

  2010cited by this paper
• Role of testosterone in the treatment of hypoactive sexual desire disorder.

  2009cited by this paper
• Sexual functioning in postmenopausal women not taking hormone therapy in the Gynecological and Menopause Clinic, Songklanagarind Hospital measured by Female Sexual Function Index questionnaire.

  2008cited by this paper
• Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.

  2007cited by this paper
• Effects of testosterone treatment on endometrial proliferation in postmenopausal women.

  2007cited by this paper
• Hypopituitarism : A Randomized , Double-Blind , Placebo-Controlled Study Effects of Testosterone Replacement in Androgen-Deficient Women with Society

  2006cited by this paper
• Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study

  2006cited by this paper
• Androgen and menopause

  2006cited by this paper
• Effects of intranasal 17&bgr;-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women

  2006cited by this paper
• The Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores

  2005cited by this paper
• Testosterone for peri- and postmenopausal women.

  2005cited by this paper
• A new oral testosterone undecanoate formulation

  2003cited by this paper
• Validation of the Female Sexual Function Index (FSFI) in Women with Female Orgasmic Disorder and in Women with Hypoactive Sexual Desire Disorder

  2003cited by this paper
• Validated Instruments for Assessing Female Sexual Function

  2002cited by this paper
• Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being

  2002cited by this paper
• Administration of Testosterone Undecanoate in Postmenopausal Women: Effects on Androgens, Estradiol, and Gonadotrophins

  2000cited by this paper
• Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

  2000cited by this paper
• The Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function

  2000cited by this paper
• Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.

  1997cited by this paper
• Nams Continuing Medical Education Activity

  year unknowncited by this paper

• Female Sexual Function and Dysfunction.

  2025cites this paper
• Effects of Testosterone Hormone on the Sexual Aspect of Postmenopausal Women: A Systematic Review

  2024influential citation
• Testosterone and sexual function in menopausal women based on the Female Sexual Function Index (FSFI) score

  2023cites this paper
• Hormone therapy for sexual function in perimenopausal and postmenopausal women.

  2023cites this paper
• Androgen Therapy in Women with Testosterone Insufficiency: Looking Back and Looking Ahead

  2022cites this paper
• The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review

  2022cites this paper
• Effect of Zinc on Testosterone Levels and Sexual Function of Postmenopausal Women: A Randomized Controlled Trial

  2021cites this paper
• The sexual function among transgender women who have undergone gender-affirming surgery using penile skin inversion vaginoplasty in Thailand

  2021cites this paper
• Effects of vaginal administration of conjugated estrogens tablet on sexual function in postmenopausal women with sexual dysfunction: a double-blind, randomized, placebo-controlled trial

  2020cites this paper
• Determinants of menopause-related symptoms in women during the transition to menopause and the postmenopausal period – A systematic literature review

  2020influential citation
• Variation in outcome reporting and measurement tools in clinical trials of treatments for genitourinary symptoms in peri- and postmenopausal women: a systematic review.

  2020cites this paper
• Correlation between general health and sexual function in older women in an Iranian setting

  2020cites this paper
• Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review

  2020cites this paper
• Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women

  2019cites this paper
• A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women

  2019cites this paper
• Testosterone Therapy: Oral Androgens

  2017cites this paper
• The Textbook of Clinical Sexual Medicine

  2017cites this paper
• Laparoscopic radical surgery in early-stage cervical cancer : short-term and long-term outcomes and survival analysis

  2017influential citation
• Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

  2017cites this paper
• Sexual health after breast cancer: Recommendations from the Spanish Menopause Society, Federación Española de Sociedades de Sexología, Sociedad Española de Médicos de Atención Primaria and Sociedad Española de Oncología Médica.

  2017cites this paper
• Sex and Pharmacological Sexual Enhancement

  2017cites this paper
• exual health after breast cancer : Recommendations from the Spanish enopause Society

  2017cites this paper
• Comparison of the short-term and long-term outcomes of laparoscopic hysterectomies and of abdominal hysterectomies: a case study of 4,895 patients in the Guangxi Zhuang Autonomous Region, China

  2016influential citation